Verax Lifesciences Private Limited

Pharmaceutical company manufacturing and exporting medicines, healthcare and food products in India and abroad.

2009 | Solan, Himachal Pradesh (India) | Active
Last Updated:

Verax Lifesciences Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.98 M
  • Company Age 15 Year, 7 Months
  • Last Filing with ROC 31 Mar 2022
  • Revenue Growth 42.36%
  • Profit Growth -95.48%
  • Ebitda -50.37%
  • Net Worth 0.86%
  • Total Assets 27.73%

About Verax Lifesciences

Verax Lifesciences Private Limited (VLPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 July 2009 and has a history of 15 years and seven months. Its registered office is in Solan, Himachal Pradesh, India.

The Corporate was formerly known as Trimurti Vegoils Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.98 M, as per Ministry of Corporate Affairs (MCA) records.

Natarajan Kumaran, Devarajan Nivetha, and Kuppusamy Ramadas serve as directors at the Company.

Company Details

  • Location

    Solan, Himachal Pradesh, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U36102HP2009PTC031136

  • Company No.

    031136

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    14 Jul 2009

  • Date of AGM

    26 Sep 2022

  • Date of Balance Sheet

    31 Mar 2022

  • Listing Status

    Unlisted

  • ROC Code

    Roc Himachal Pradesh

Industry

Pharma

Who are the key members and board of directors at Verax Lifesciences?

Board Members (3)

NameDesignationAppointment DateStatus
Natarajan Kumaran Country flag representing In Director 16-May-2016Current
Devarajan Nivetha Country flag representing In Director 26-Aug-2022Current
Kuppusamy Ramadas Country flag representing Tw Director 19-Aug-2022Current

Financial Performance of Verax Lifesciences.

Verax Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 42.36% increase. The company also saw a substantial fall in profitability, with a 95.48% decrease in profit. The company's net worth moved up by a moderate rise of 0.86%.

Verax Lifesciences revenue growth over time
Verax Lifesciences profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
42.36%
Revenue from Operations
41.99%
Total Assets
27.73%
Profit or Loss
-95.48%
Net Worth
0.86%
EBITDA
-50.37%

What is the Ownership and Shareholding Structure of Verax Lifesciences?

Unlock access to Verax Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Verax Lifesciences?

Verax Lifesciences has a workforce of 14 employees as of Sep 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Verax Lifesciences Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Verax Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Verax Lifesciences's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Verax Lifesciences

Recent activity within the organization

  • Annual General Meeting

    Verax Lifesciences Private Limited last Annual general meeting of members was held on 26 Sep 2022 as per latest MCA records.

  • Director Appointment

    Devarajan Nivetha was appointed as a Director was appointed as a Director on 26 Aug 2022 & has been associated with this company since 2 years 6 months .

  • Director Appointment

    Kuppusamy Ramadas was appointed as a Director was appointed as a Director on 19 Aug 2022 & has been associated with this company since 2 years 6 months .

  • Balance Sheet

    Verax Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Himachal Pradesh.

  • Director Appointment

    Natarajan Kumaran was appointed as a Director was appointed as a Director on 16 May 2016 & has been associated with this company since 8 years 9 months .

  • Company Incorporation

    Verax Lifesciences Private Limited was registered on 14 Jul 2009 with Roc Himachal Pradesh & aged 15 years 7 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Verax Lifesciences Private Limited?

    Verax Lifesciences Private Limited was incorporated on 14 Jul 2009.

  • What is authorized share capital and paid-up capital of Verax Lifesciences Private Limited?

    The authorized share capital of Verax Lifesciences Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.98 M.

  • Who are the current board members & directors of Verax Lifesciences Private Limited?

    Currently 3 directors are associated with Verax Lifesciences Private Limited.

    • Natarajan Kumaran
    • Devarajan Nivetha
    • Kuppusamy Ramadas

  • What is the registered address of Verax Lifesciences Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Verax Lifesciences Private Limited is Khasra No. 435 Village Surajmajra N.H. 21, India, Baddi, Himachal Pradesh, 173205.

  • What is the corporate identification number (CIN) and company number of Verax Lifesciences Private Limited?

    The corporate identification number (CIN) of Verax Lifesciences Private Limited is U36102HP2009PTC031136 and the company number is 031136 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Verax Lifesciences Private Limited?

    According to the financial reports for the fiscal year 2022, the revenue trend for Verax Lifesciences Private Limited has risen by 42.36%.

  • How many employees does Verax Lifesciences Private Limited currently have?

    As Per 2022 financial reports, 14 employees are currently employed by Verax Lifesciences Private Limited.

  • What change has been observed in the net worth of Verax Lifesciences Private Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Verax Lifesciences Private Limited has experienced an upsurge of 0.86%.

  • When was the last Balance Sheet of Verax Lifesciences Private Limited filed with the ROC?

    The most recent Balance Sheet for Verax Lifesciences Private Limited was filed with the ROC on 31 Mar 2022.

People also Viewed

Similar Companies Based on Drug Formulation & Development